Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D3110
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 1,349 $2,895,263 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $2,895,263 Current and potential, with all options
- Last date to order 9% complete
- IDV ceiling <1% used
- $9,999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award SPE2DR25D3110 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support global military healthcare programs through December 2036.
This IDC serves as the primary contracting vehicle for the DLA Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which aims to establish prime vendor contracts for worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet. The contracted commodities encompass brand-name and generic drugs, specialty medications, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract is structured as a firm-fixed price, requirements-type contract with a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. This unrestricted, fully competitive acquisition will result in multiple regional primary supplier awards, ensuring the Department of Defense's resilience and access to vital pharmaceuticals during contingencies or natural disasters.
Task orders
Show 40 more
Latest 50 of 1,349 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D3110?
SPE2DR25D3110 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D3110 worth?
Orders under SPE2DR25D3110 have obligated $2,895,263. SPE2DR25D3110's own ceiling is $9,999,999,999.
How many orders have been placed under contract SPE2DR25D3110?
1,349 orders have been placed under SPE2DR25D3110, the latest on July 28, 2026.
Who can order from contract SPE2DR25D3110?
SPE2DR25D3110 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D3110 competed?
The extent of competition for SPE2DR25D3110 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV